Healthcare ❯ Pharmaceuticals ❯ Clinical Trials
Weight Loss Treatment Elinzanetant Eli Lilly Azelaprag Vibozilimod
Takeda targets a March filing after trials showed longer wakefulness with large reductions in cataplexy.